Lataa...
Practical Considerations for Using Novel Oral Anticoagulants in Patients With Atrial Fibrillation
Novel oral anticoagulants, including dabigatran, rivaroxaban, and apixaban, represent new options for preventing stroke in patients with atrial fibrillation, as shown by the results from large, randomized phase III trials. Because of their greater specificity, rapid onset of action, and predictable...
Tallennettuna:
| Julkaisussa: | Clin Cardiol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Wiley Periodicals, Inc.
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6649642/ https://ncbi.nlm.nih.gov/pubmed/24254991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.22204 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|